miR-338–3p acts as a tumor suppressor in gastric cancer, inhibiting cell growth, survival, and proliferation by directly targeting SOX5 and blocking Wnt/β-catenin signaling, while inducing apoptosis (54). Here, SOX5 is linked to neoplasm.